The number of people with susceptibility test result for rifampicin in Tajikistan

Tajikistan: The number of people with susceptibility test result for rifampicin was 1,862 in 2021. ▼ Falling

Latest (2021)
1,862
Change on year
up 10.6%
World rank
50th
of 155 countries
All-time high
2,487
in 2018
All-time low
1,683
in 2020
Years of data
5
2017–2021

The number of people with susceptibility test result for rifampicin in Tajikistan, 2017–2021

05001.0k1.5k2.0k2.5k2017201920212017: 2.4k2018: 2.5k2019: 2.3k2020: 1.7k2021: 1.9k

Source: World Health Organization, Global Health Observatory.

Analysis

The most recent figure for the number of people with susceptibility test result for rifampicin in Tajikistan is 1,862, measured in 2021.

Compared with earlier readings it is up 10.6% on the previous year and down 23.4% over five years.

That places Tajikistan 50th out of 155 countries with data for 2021, putting it in the middle of the range.

The number of people with susceptibility test result for rifampicin in Tajikistan, year by year

Annual values for The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients. in Tajikistan, 2017 to 2021.
Year Value Change
2017 2,432
2018 2,487 +2.3%
2019 2,318 -6.8%
2020 1,683 -27.4%
2021 1,862 +10.6%

Tajikistan compared with similar countries

  • Tajikistan's 1,862 is below the median for lower middle income countries, which is 2,804, 66% of the median. (32 countries reporting)
  • Tajikistan's 1,862 is above the median for Europe & Central Asia, which is 229.5, 8.1× the median. (44 countries reporting)

Averages by decade

DecadeAverage LowestHighest Years
2010s 2,412 2,318 2,487 3
2020s 1,772 1,683 1,862 2

Countries ranked near Tajikistan

  1. 47 Congo 2,015 compare
  2. 48 Guinea-Bissau 1,934 compare
  3. 49 Kyrgyzstan 1,932 compare
  4. 51 Iran, Islamic Republic of 1,828 compare
  5. 52 Togo 1,805 compare
  6. 53 Chile 1,772 compare

See the full ranking of 157 places →

More health data for Tajikistan

All data for Tajikistan →

Frequently asked questions

What is the number of people with susceptibility test result for rifampicin in Tajikistan?
The number of people with susceptibility test result for rifampicin in Tajikistan was 1,862 in 2021, according to World Health Organization, Global Health Observatory.
What is the highest the number of people with susceptibility test result for rifampicin recorded in Tajikistan?
The highest recorded value was 2,487 in 2018.
What is the lowest the number of people with susceptibility test result for rifampicin recorded in Tajikistan?
The lowest recorded value was 1,683 in 2020.
How does Tajikistan rank for the number of people with susceptibility test result for rifampicin?
Tajikistan ranks 50th out of 155 countries with data for 2021.
Where does this Tajikistan data come from?
The figures come from World Health Organization, Global Health Observatory, published as part of The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.. Statizoid updates them automatically from the source API.

Download this data

CSV · JSON — 5 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).

Share, cite or embed this page

Cite this page

The number of people with susceptibility test result for rifampicin in Tajikistan. Statizoid, drawing on World Health Organization, Global Health Observatory. Retrieved 17 September 2026, from https://health.statizoid.com/stat/the-number-of-people-with-susceptibility-test-result-for-rifampicin-among/tajikistan/

Embed or link this data

Paste this into a page to link back to these figures. The data itself is free to reuse under CC BY-NC-SA 3.0 IGO (WHO); please keep the attribution.

<a href="https://health.statizoid.com/stat/the-number-of-people-with-susceptibility-test-result-for-rifampicin-among/tajikistan/">The number of people with susceptibility test result for rifampicin in Tajikistan</a> — Statizoid

About this data

Indicator
The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.
Source
World Health Organization, Global Health Observatory
Licence
CC BY-NC-SA 3.0 IGO (WHO)
Coverage
157 places, 785 data points, 2017–2021
Last refreshed